Association of TNF-α gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study by Chen, Yi-Chun et al.
Chen et al. BMC Neurology 2010, 10:41
http://www.biomedcentral.com/1471-2377/10/41
Open Access RESEARCH ARTICLE
© 2010 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Association of TNF-α gene with spontaneous deep 
intracerebral hemorrhage in the Taiwan 
population: a case control study
Yi-Chun Chen1, Fen-Ju Hu2, Phoebe Chen3, Yih-Ru Wu1, Hsiu-Chuan Wu1, Sien-Tsong Chen1, Guey-Jen Lee-Chen*2 
and Chiung-Mei Chen*1
Abstract
Background: Genetic factors may play a role in susceptibility to spontaneous deep intracerebral hemorrhage (SDICH). 
Previous studies have shown that TNF-α gene variation was associated with risks of subarachnoid hemorrhage in 
multiple ethnicities. The present case-control study tested the hypothesis that genetic variations of the TNF-α gene 
may affect the risk of Taiwanese SDICH. We examined the association of SDICH risks with four single nucleotide 
polymorphisms (SNPs) within the TNF-α gene promoter, namely T-1031C, C-863A, C-857T, and G-308A.
Methods: Genotyping was determined by PCR-based restriction and electrophoresis assay for 260 SDICH patients and 
368 controls. Associations were tested by logistic regression or general linear models with adjusting for multiple 
covariables in each gender group, and then in combined. Multiplicative terms of gender and each of the four SNPs 
were applied to detect the interaction effects on SDICH risks. To account for the multiple testing, permutation testing 
of 1,000 replicates was performed for empirical estimates.
Results: In an additive model, SDICH risks were positively associated with the minor alleles -1031C and -308A in men 
(OR = 1.9, 95% CI 1.1 to 3.4, p = 0.03 and OR = 2.6, 95% CI 1.3 to 5.3, p = 0.005, respectively) but inversely associated with 
-863A in females (OR = 0.5, 95% CI 0.2 to 0.9, p = 0.03). There were significant interaction effects between gender and 
SNP on SDICH risks regarding SNPs T-1031C, C-863A, and G-308A (p = 0.005, 0.005, and 0.007, respectively). 
Hemorrhage size was inversely associated with -857T in males (p = 0.04).
Conclusions: In the Taiwan population, the associations of genetic variations in the TNF-α gene promoter with SDICH 
risks are gender-dependent.
Background
Deep parenchymal structure including the basal ganglia,
thalamus, brainstem, and cerebellum is the most fre-
quently (65% to 80%) affected site of spontaneous intrace-
rebral hemorrhage (SICH) [1,2]. SICH developing at deep
parenchymal structure (SDICH) varies in size and loca-
tion, and thus differs in clinical presentations and prog-
nosis according to the arteries that have ruptured. SICH
is a devastating stroke subtype, in which the six-month
and one-year mortality rate of SICH ranged from 23% to
58% and >50%, respectively [3,4]. The 30-day mortality
rate is associated with the initial Glasgow Coma Scale and
hemorrhage size [5]. In addition, males tended to have a
higher risk (more than twice), larger hemorrhage size,
and a poorer outcome than females [3,6]. We have shown
sex differences in the etiological spectrum of SDICH in
the young, in which cryptogenic etiology and underlying
vascular anomaly are significantly higher in females while
hypertension attributes to a higher SDICH risk in males
[6].
A recent article comprehensively reviewed the candi-
date genes of SICH reported during 1996 to 2007 [7].
Candidate genes reported as associated with SICH were
involved in the pathways of the vessel wall integrity (ACE,
APOE, neprilysin, endoglin, TGF-β1), endothelial dys-
function (ACE), inflammation markers (IL-6, TNF), and
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hemostasis (APOE, CD-14, Factor VII and XIII,
VKORC1). However, these studies were mainly con-
ducted in lobar SICH. In contrast, the number of genetic
studies of SDICH is limited [2,8-10].
As a complex disease, SDICH aggregate in families but
does not segregate in a mendelian fashion [2,6,11]. Family
aggregation in SDICH group suggests involvement of
shared genetic and/or environmental factors on SDICH
risks [2,10]. To our knowledge, susceptibility genes of
SDICH remain largely unknown. Although hypertension
is the most important risk factor for SDICH [3,12], it
accounts for only 54% of SDICH cases [2]. Genetic pre-
disposition has been speculated to account for the novel
pathophysiology, including hemostatic pathway, path-
ways involving endoglin and cytochrome P450 [13].
Concentrations of inflammation markers in plasma and
cerebral spinal fluid have been shown to be positively cor-
related with mortality in SICH patients [14]. Tumor
necrosis factor α (TNF-α) is one of the main proinflam-
matory cytokines and plays a central role in initiating and
regulating the inflammatory response. The TNF-α gene is
located in 6p21.3. Previous studies have shown that poly-
morphisms at position -308 and -863 in the promoter
region of the TNF-α gene were associated with risks of
subarachnoid hemorrhage (SAH) in multiple ethnicities
[15,16]. Differences in transcriptional activator resulting
in different TNF-α concentrations may contribute to this
association [17,18]. In contrast to the finding in SAH,
there is no evidence showing an association of TNF-α
polymorphism with SICH in a Japanese study [16]. To our
knowledge, there is no report addressing the association
of TNF-α polymorphism with SDICH risk.
The purpose of this study is to evaluate whether any
particular polymorphism of TNF-α gene would predis-
pose to SDICH and modify the 30-day outcome of
SDICH events in the Taiwan population.
Methods
Subjects
This is a retrospective case-control study. Subjects were
recruited from the Department of Neurology, Chang
Gung Memorial Hospital (CGMH), Linkou Medical Cen-
ter, which is a tertiary referral center serving residents
m a i n l y  i n  t h e  n o r t h e r n  T a i w a n .  P a t i e n t s  w i t h  S D I C H
were diagnosed based on both clinical presentations and
brain computed tomography (CT) [3,10,19]. Clinical pre-
sentations included a nontraumatic, abrupt onset of
severe headaches, focal neurologic deficit, or altered con-
sciousness level related to hematoma at the brain paren-
chyma that was not due to hemorrhagic transformation
o f  a  c e r e br al  infa r ct.  CT  o f  br ai n is  t he  fir st -c hoi c e  of
imaging options to identify the presence of acute intrace-
rebral hemorrhage and its size and location [19]. Inclu-
sion criteria for SDICH cases were (i) patients with
SDICH and (ii) a patient or her/his legally acceptable rep-
resentative, willing to provide written informed consent
to participate. Patients with a SAH, traumatic hemor-
rhage, brain tumor, vascular anomaly, abnormal platelet
count, prolonged prothrombin time, and prolonged acti-
vated partial thromboplastin time were excluded. Partici-
pants of the control group were recruited randomly from
the community of the Northern Taiwan and met the fol-
lowing inclusion criteria: (i) subjects providing informed
consent, (ii) subjects who came to CGMH for a health
examination or treatment for diseases other than neuro-
degenerative diseases, inflammatory diseases, or cerebro-
vascular diseases (CVDs), (iii) no medical history of
neurodegenerative diseases, inflammatory diseases, and
CVDs, and (iv) all the medical records were reviewed by
at least two neurologists. Approximate 90% of the con-
trols were enrolled from subjects who visited for health
examination. This study was approved by the Institu-
tional Review Board of CGMH.
Clinical information
Anthropometric data and 12-hour fasting blood were col-
lected from all participants. For SDICH cases, blood was
drawn within one week of event in average. Diabetes mel-
litus (DM) was defined based on World Health Organiza-
tion (WHO) criteria. Hypertension was diagnosed when
b l o o d  p r e s s u r e  ( B P )  r e p e a t e d l y  e x c e e d e d  1 4 0  m m  H g
(systolic) and/or 90 mm Hg (diastolic) or when a subject
was taking antihypertensive medication to control hyper-
tension. For SDICH cases without prior diagnosis of
hypertension, patients were considered to have hyperten-
sion when BP measured after the acute phase of SDICH
(14 days within the onset of hemorrhage) repeatedly
exceeded 140 mm Hg (systolic) and/or 90 mm Hg (dia-
stolic). Body mass index (BMI) was calculated by weight
in kilograms divided by squared height in meters. Alcohol
use was defined as drinking ≥210 g per week.
Hemorrhage located at the basal ganglia and thalamus
was defined as supratentorium SDICH, while brainstem
and cerebellum hemorrhage were defined as infratento-
rium SDICH. Volume of the hematoma was calculated
using the so-called ABC method based on CT of brain
[5]. Short term outcome was assessed using the modified
Rankin scale (mRS) on day 30 after SDICH events. Sub-
jects who were dead or dependent (mRS >3) at the 30 day
follow-up were considered poor prognosis [20].
Genotyping
Genomic DNA was isolated from peripheral leukocytes
using DNA Extraction Kit (Stratagene). Genotypes for
TNF-α  T-1031C, C-863A, C-857T, and G-308A were
determined by PCR-based single-strand conformation
polymorphism (SSCP) and/or restriction fragment length
polymorphism (RFLP) assays. The details of specific PCRChen et al. BMC Neurology 2010, 10:41
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conditions and detection for genotyping, including poly-
morphism primer pair, anneal, and enzyme were
described in our previous report [21]. The amplified
products were digested with the appropriate restriction
enzyme (New England Biolabs, Beverly, MA) and subse-
quently separated on 1.8%~2.2% agarose gels. In addition,
aliquots of the amplified products were mixed with an
equal volume of 95% formamide buffer and subjected to
SSCP and heteroduplex analyses using GeneGel Excel
gels as recommended by the manufacturer (Pharmacia
Biotech, Uppsala, Sweden).
E a c h  o f  t h e  f o u r  s i n g l e  n u c l e o t i d e  p o l y m o r p h i s m s
(SNPs) was checked for Hardy-Weinberg equilibrium
(HWE) using the standard χ2 test with significance level
of 0.001 in each of the case and control groups and in the
combined group. Patterns of linkage disequilibrium (LD)
were evaluated using Haploview v4 [22], and haplotypes
were reconstructed by PHASE 2.0 [23] based on the LD
results. Haplotypes with frequency <1% were excluded
from association analysis.
Statistical analysis and power estimation
The Pearson's χ2-test or t-test was utilized to compare
demographic data and the distributions of genotypes of
TNF-α between controls and cases. Two-tailed P-values
were derived from the χ2-test or Fisher's exact test. Asso-
ciation analyses were performed first stratified by gen-
ders, and then in combined. Multivariable logistic
regression was used to analyze the phenotype-genotype
associations of SDICH with TNF-α alleles under additive
genetic models. Covariables included age, sex, BMI, and
hypertension, total cholesterol level, and alcohol use [3].
Because hematoma size is affected by its location, the
association between hematoma and genotype effect was
analyzed only in hemorrhages that were located at
supratentorium. Associations between hematoma size
and each of the SNPs were examined by general linear
models (GLM). To examine interaction effects between
gender and each of the SNPs, the multiplicative term of
genotypes and gender was included and evaluated in the
same additive model as the interaction term. Permutation
testing of 1,000 replicates was performed for empirical
estimates as a robust alternative to standard parametric
tests. Permutation testing was performed only when the
preliminary P-value was <0.05.
In the present case-control study, at the 5% significance
level, we had power greater than 0.8 to identify an associ-
ation under an additive genetic model when the per-allele
genetic effect was greater than an odds ratio of 1.5 and
the disease allele frequency was greater than 0.2.
All the data analyses were performed using SAS soft-
ware version 9.1.3 (SAS Institute, Cary, NC, USA).
Results
The characteristics of the study groups are presented in
Table 1. A total of 260 SDICH patients and 368 controls
were included in this study. Age and gender distribution
did not differ between SDICH patients and controls. The
proportions of hypertension and alcohol use were signifi-
cantly higher in patients than in controls. Cases had
lower concentration of total cholesterol (TC) than con-
trols. Proportions of risk factors of SDICH were slightly
different between genders, in which the proportion of
DM was significantly higher in the female but not in the
male patients. In SDICH cases, males had a lower propor-
tion of supratentorium hemorrhage and larger hemor-
rhage size than females (Table 1). There was no
significant gender difference in the 30-day outcome esti-
mated by mRS.
In the entire cohort, distributions of all the four SNPs
did not differ between SDICH cases and controls (Table
2). When stratified by genders, distributions of T-1031C
and G-308A were significantly different between cases
and controls in males (χ2 test, p = 0.01 and p = 0.02,
respectively). In contrast, the distribution of C-857T dif-
fered significantly between cases and controls in females
(χ2 test, p = 0.002) but not in males. Each of the four SNPs
was in HWE in each of the case and control groups and in
the combined group. The minor allele frequencies of all
the four SNPs were ≥ 0.05, and therefore we utilized the
four SNPs to evaluate LD. There was a single block struc-
ture, composed of a portion of the SNPs T-1031C and C-
863A with D' estimation of 0.92.
When adjusting for age, sex, BMI, hypertension, TC
level, and alcohol use, logistic regression showed associa-
tions of the four SNPs with SDICH risks in a different
direction in each gender group. Specifically, in an additive
model, SDICH risks were positively associated with the
minor alleles of SNPs -1031C and -308A in men (OR =
1.9, 95% CI 1.1 to 3.4, p = 0.03 and OR = 2.6, 95% CI 1.3 to
5.3, p = 0.005, respectively) but inversely associated with -
863A in women (OR = 0.5, 95% CI 0.2 to 0.9, p = 0.03).
These associations were not significant in the combined
cohort because of the opposite direction of associations
in each gender group. Multiplicative terms of SNPs and
gender evaluated in the same additive models showed sig-
nificant SNP-gender interaction effects on SDICH risks
regarding SNPs T-1031C, C-863A, and G-308A (p =
0.005, 0.005, and 0.007, respectively). Haplotypes con-
structed by the SNPs T-1031C and C-863A were not
associated with the SDICH risks in each gender group
and in the combined group (data not shown).
In the SDICH group, 149 in 177 (84.2%) males and 80 in
83 (96.4%) females had hemorrhage located at supraten-
torium (gender difference p = 0.005, χ2 test) (Table 1).
Hemorrhage located at supratentorium was larger in size
in males (18.0 ± 1.6 cm3) than in females (13.1 ± 1.6 cm3,Chen et al. BMC Neurology 2010, 10:41
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t-test, p = 0.03). There was no association of hemorrhage
location with any of the four SNPs (p > 0.05, data not
shown). Regarding hemorrhage size, only SNPs C-857T
showed a borderline association in male group after
adjusting age, BMI, alcohol use, and hypertension in
additive model (Table 3). The hemorrhage size decreased
by 6.0 ± 4.0 cm3 per minor allele for the -857T variant
(parameter estimates derived from GLM models, p =
0.04). No significant SNPs-gender effect on hemorrhage
size was found. Haplotypes constructed by the SNPs T-
1031C and C-863A were not associated with hemorrhage
size in each gender and in the combined group.
The 30-day short term outcome including dependency
or death was remarkably correlated with age (multiple
logistic regression, p = 0.003) and hematoma size (p <
0.001) (data not shown in tables), but neither with any of
the four SNPs nor the constructed haplotypes in the
male, female, and in the combined groups. There was no
SNP-gender interaction effect on short term outcome.
Discussion
Knowledge of susceptibility genes of SDICH, a common
complex disease, is largely lacking because of the study
obstacles of the need of a priori knowledge of gene func-
tion, modest genetic effect, polygenic effect, and epista-
sis. The study herein shows that the common genetic
variations of TNF-α gene are associated with SDICH risks
with significant gender differences. The direction of asso-
ciations between TNF-α  gene and SDICH is opposite
between genders. In an additive model, SDICH risks are
positively associated with the dose of minor alleles of -
1031C and -308A in men, but inversely associated with -
863A in female. Multiplicative terms of analyses confirm
the interaction effects between gender and each of the
SNPs T-1031C, C-863A, and G-308A on SDICH risks.
Hemorrhage size is inversely associated with -857T allele
in males. No association between the 30-day outcome
and TNF-α gene is found in this study. Haplotypes con-
structed by the SNPs T-1031C and C-863A did not reveal
any association with SDICH risks, hemorrhage size, and
mRS.
Increased serum TNF-α, one of the main proinflamma-
tory cytokines regulating an inflammatory response, has
been demonstrated to be associated with increased mor-
tality rate of SICH [14] and recurrent stroke [24]. Previ-
ous studies have demonstrated that the G allele of the G-
308A in the Italy population [15] and the A allele of the
C-863A in the Japanese population [16] are associated
w i t h  S A H  r i s k s .  I t  i s  w o r t h  m e n t i o n i n g  t h a t  t h e  I t a l y
study [15] consisted of more women (n = 115) than men
(n = 56), and the analyses in their study was not stratified
by gender. In contrast, there was no association between
SICH risks and SNPs of C-863A, C-850T, G-238A in the
Japanese population [16]. This study, however, shows
associations between SDICH risks and each of the SNPs
T-1031C, C-863A, and G-308A. The strength of our
study to show the significant results partly comes from
the homogeneous phenotype in our study, in contrast to
the previous Japanese study which included both lobar
SICH and SDICH [13,16]. Lobar hemorrhage and non-
lobar hemorrhage are considered to be attributable to dif-
ferent etiologies [25]. The major cause of SDICH is
Table 1: Demographic data in patients with spontaneous deep intracerebral hemorrhage (SDICH) and controls
Males (n = 403) Females (n = 225) Both genders (n = 628)
SDICH
(n = 177)
Controls
(n = 226)
P-Value SDICH
(n = 83)
Controls
(n = 142)
P-Value SDICH
(n = 260)
P-Value
Age (years) 58.3 ± 1.0 58.7 ± 0.9 0.82 65.1 ± 1.3 62.6 ± 0.9 0.05 0.61
Hypertension (%) 91.5 32.3 <0.0001 95.2 38.7 <0.0001 <0.0001
Diabetes mellitus (%) 12.4 15.9 0.35 30.1 13.4 0.004 0.32
Alcohol use (%) 46.9 19.5 <0.0001 4.8 0 0.018 <0.0001
Body mass index (kg/m2) 25.2 ± 0.3 25.8 ± 0.3 0.13 24.4 ± 0.4 25.1 ± 0.4 0.31 0.08
Total cholesterol (mg/dL) 176.9 ± 2.7 191.7 ± 3.0 0.0003 188.3 ± 4.1 204.6 ± 3.7 0.003 <0.0001
Triglyceride (mg/dL) 137.9 ± 6.1 143.7 ± 6.9 0.90 143.8 ± 8.3 147.3 ± 8.0 0.80 0.77
SDICH at supratentorium 149 (84.2%) 80 (96.4%) 229 (88.1%) 0.005a
Hemorrhage size (cm3)b 18.0 ± 1.6 13.1 ±1.6 16.3 ±1.2 0.03a
modified Rankin scale > 3 49.1% 52.5% 50.2% 0.62a
Data are expressed as percentage or mean ± SE. Comparisons between controls and SDICH cases were analyzed by χ2 test or t-test where 
appropriate. To convert mg/dL to mmol/L, multiply cholesterol values by 0.02586 and triglycerides by 0.011.
aComparisons between genders. bAverage size in those with supratentorium SDICH.Chen et al. BMC Neurology 2010, 10:41
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hypertension [1,2,12], while lobar SICH is related to cere-
bral amyloid angiopathy [3]. In addition, the sample size
of our study is larger than the prior one and thus had
more power to identify the association between SNPs and
SDICH risk. However, the present study only suggested
modest genetic effects on SDICH risks.
Polymorphisms in the regulatory region of promoter
may result in different TNF-α concentration. The SNPs -
308A [17], -1031C, -863A, and -857T [18] have been
shown to be associated with increasing TNF-α expres-
sion. Possible mechanisms of the influence may come
from substances binding to regulatory elements, such as
nuclear factor κB and organic cation transporter 1, and
alteration of the secondary structure of DNA to affect
accession of cis-acting transcription factors to the pro-
moter/enhancer region of the TNF-α gene [26,27]. The
study herein showed remarkable gender differences in the
associations between promoter polymorphisms of TNF-α
and SDICH risks. In males, we found that minor alleles of
the TNF-α variation are risks to SDICH as hypothesized.
However, the direction of the association was opposite in
females. Several clinical and experimental studies have
shown gender differences in the cytokine response to
stress [28,29]. Type 1 lymphocytes that produce interleu-
Table 2: Frequencies and associations of TNF-α genotypes in patients with spontaneous deep intracerebral hemorrhage 
(SDICH) and controls
Males (n= 403) Females (n = 225) Total
SNP SDICH
(n = 177)
Controls
(n = 226)
P-Value,
OR (95% CI) 
SDICH
(n = 83)
Controls
(n = 142)
P-Value,
OR (95% CI) 
P-Value,
OR (95% CI) 
T-1031C P = 0.03,
1.9 (1.1 to 3.4)
P = 0.06,
0.5 (0.3 to 1.02)
P = 0.65,
1.1 (0.7 to 1.7)
TT 119 (67.2) 169 (74.8) 52 (62.7) 86 (60.6)
TC 48 (27.1) 55 (24.3) 31 (37.4) 49 (34.5)
CC 10 (5.7) 2 (0.9) 0 (0.0) 7 (4.9)
C-863A P = 0.09,
1.6 (0.9 to 2.7)
P = 0.03,
0.5 (0.2 to 0.9)
P = 0.99,
1.0 (0.7 to 1.5)
CC 120 (67.8) 163 (72.1) 54 (65.1) 85 (59.9)
CA 46 (26.0) 59 (26.1) 28 (33.7) 49 (34.5)
AA 11 (6.2) 4 (1.8) 1 (1.2) 8 (5.6)
C-857T P = 0.20,
0.7 (0.4 to 1.2)
P = 0.21,
1.6 (0.8 to 3.3)
P = 0.86,
0.9 (0.6 to 1.5)
CC 132 (74.6) 163 (72.1) 52 (62.7) 116 (81.7)
CT 43 (24.3) 59 (26.1) 30 (36.1) 22 (15.5)
TT 2 (1.1) 4 (1.8) 1 (1.2) 4 (2.8)
G-308A P = 0.005,
2.6 (1.3 to 5.3)
P = 0.18,
0.6 (0.2 to 1.3)
P = 0.19,
1.4 (0.8 to 2.4)
GG 129 (72.9) 190 (84.1) 67 (80.7) 104 (73.2)
GA 44 (24.9) 33 (14.6) 15 (18.1) 37 (26.1)
AA 4 (2.3) 3 (1.3) 1 (1.2) 1 (0.7)
Values are n (%). OR: Odds ratio; CI: confidence interval. Logistic regression analyses, adjusting for age, sex, BMI, hypertension, total cholesterol 
level, and alcohol use in an additive model. P-values in bold were empirical p-values that estimated by permutation of 1000 replicates.Chen et al. BMC Neurology 2010, 10:41
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kin (IL)-12, IL-1β and TNF-α  are increased in men as
compared to women after experimental lymphocyte
stimulation in an ex vivo study [28].
Our study also showed an inverse association of -857T
with hemorrhage size in males. Because of the antifibrin-
olytic effects of TNF-α by stimulating the release of plas-
minogen activator inhibitor type 1 and by reducing the
release of t-PA through the extrinsic route [30], the
release of TNF-α may be responsible for the early activa-
tion of hemostatic mechanism during a SDICH event
[31]. The -857T allele may produce a higher level of TNF-
α, which may in turn decrease the hemorrhage size.
It is worth mentioning that patients in this study were
ascertained from the Department of Neurology, which
might cause a smaller average hemorrhage size than that
of patients in the Department of Neurosurgery. Further-
more, this study does not have sufficient subjects of
infratentorium hemorrhage to examine the correlation
between genetic effects and the significant gender differ-
ence in the hemorrhage loci. Also, the number of female
cases is relatively small, which is due to a lower incidence
rate compared to males [32] rather than selection bias. A
multiplicative term of gender and SNPs showed signifi-
cant interaction effects between gender and SNPs T-
1031C, C-863A, and G-308A. Further replicated study is
needed to confirm the results herein, especially regarding
the hemorrhage size and short term outcome. In addi-
tion, the SNPs we studied may not pose a specific risk fac-
tor for SDICH, given that these SNPs could be a risk
factor for numerous conditions [18,21,27]. This report is
preliminary, the effect sizes are small and the study will
need to be replicated before these SNPs can be viewed as
independent risk factors for SDICH. The other limitation
of this study is that we did not measure serum TNF-α
concentration, which may otherwise provide additional
functional information to support our hypothesis. A fur-
ther study examining the correlation between the SNPs
and serum TNF-α concentration will be useful. Neverthe-
less, our study has several strengths. This study included
a homogenous disease entity in a same ethnic back-
ground, which may limit the confounding effect from
multiple phenotypes and ethnicities. This is the first
study analyzing associations between TNF-α  genotype
and the SDICH susceptibility, and independent confirma-
tion is needed to verify these associations.
Conclusions
This study showed a modest effect of TNF-α polymor-
phisms on SDICH risks and size with significant gender
differences.
Table 3: Associations of hemorrhage size with TNF-α genotypes in patients with spontaneous deep intracerebral 
hemorrhage (SDICH)
Males Females Total
SNP Hemorrhage size (cm3) P-Value Hemorrhage size (cm3) P-Value P-Value
T-1031C 0.57 0.23 0.27
TT 18.5 ± 2.1 12.0 ± 2.2
TC 17.4 ± 2.3 14.8 ± 2.5
CC 15.1 ± 5.3 -
C-863A 0.66 0.15 0.31
CC 18.2 ± 2.0 11.9 ± 2.1
CA 18.2 ± 2.7 15.9 ± 2.7
AA 15.7 ± 5.3 2.0 ± 0
C-857T 0.04 0.58 0.23
CC 18.9 ± 1.9 12.6 ± 2.3
CT 15.5 ± 2.6 14.1 ± 2.4
TT 3.5 ± 0.5 2.0 ± 0
G-308A 0.80 0.95 0.84
GG 18.3 ± 2.0 13.2 ± 1.7
GA 17.8 ± 2.5 12.6 ± 5.1
AA 11.6 ± 3.9 15.0 ± 0
GLM models that included age, sex, BMI, hypertension, TC level, and alcohol use in an additive model. Data are expressed as mean ± SE.
P-values in bold were empirical p-values that estimated by permutation of 1000 replicates.Chen et al. BMC Neurology 2010, 10:41
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